Rhythm(RYTM) - 2025 Q3 - Earnings Call Transcript
Rhythm Pharmaceuticals (NasdaqGM:RYTM) Q3 2025 Earnings Call November 04, 2025 08:00 AM ET Company ParticipantsDavid Meeker - Chairman, CEO and PresidentJennifer Lee - EVP, Head of North AmericaHunter Smith - CFOYann Mazabraud - EVP, Head of InternationalDavid Connolly - Head of Investor RelationsConference Call ParticipantsNone - AnalystNone - AnalystFaisal Khashid - AnalystNone - AnalystDerek Archila - AnalystRaghuram Selvaraju - AnalystNone - AnalystEvan Wang - AnalystGeorgia Banks - AnalystNone - Analys ...